{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:03:58Z","timestamp":1775466238025,"version":"3.50.1"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2020\/37\/N\/NZ6\/01442"],"award-info":[{"award-number":["2020\/37\/N\/NZ6\/01442"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaut.2023.103095","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T12:52:16Z","timestamp":1696337536000},"page":"103095","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Environmental exposures as risk factors for idiopathic inflammatory myopathies"],"prefix":"10.1016","volume":"140","author":[{"given":"Aleksandra H.","family":"Opinc-Rosiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna S.","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib1","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1219-y","article-title":"Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study","volume":"19","author":"Andersson","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1568-9972(02)00055-1","article-title":"The pathogenesis of inflammatory muscle diseases: on the cutting edge among the environment, the genetic background, the immune response and the dysregulation of apoptosis","volume":"1","author":"Pignone","year":"2002","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.bor.0000141925.21941.d8","article-title":"Myositis: an update on pathogenesis","volume":"16","author":"Christopher-Stine","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-018-0286-1","article-title":"Inpatient burden of juvenile dermatomyositis among children in the United States","volume":"16","author":"Kwa","year":"2018","journal-title":"Pediatr. Rheumatol."},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/acr.23190","article-title":"Predictors of hospitalization, length of stay, and cost of care among adults with dermatomyositis in the United States","volume":"69","author":"Kwa","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib7","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s00296-022-05176-3","article-title":"New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review","volume":"42","author":"Holzer","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib8","first-page":"20","article-title":"Dermatomyositis during COVID-19 pandemic (A case series): is there a cause effect relationship?","volume":"68","author":"Gokhale","year":"2020","journal-title":"J. Assoc. Phys. India"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-021-00570-w","article-title":"COVID-19 and myositis; true dermatomyositis or prolonged post viral myositis?","volume":"19","author":"Movahedi","year":"2021","journal-title":"Pediatr. Rheumatol."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10081184","article-title":"A large cluster of new onset autoimmune myositis in the Yorkshire region following SARS-CoV-2 vaccination","volume":"10","author":"De Marco","year":"2022","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000110192","article-title":"Evidence for seasonal variation in polymyositis","volume":"8","author":"Mania","year":"1989","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib13","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/art.21198","article-title":"Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups","volume":"52","author":"Sarkar","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","article-title":"Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies","volume":"34","author":"Leff","year":"1991","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s004150200036","article-title":"Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study","volume":"249","author":"Phillips","year":"2002","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.39466","article-title":"Association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis","volume":"68","author":"Habers","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib18","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.22751","article-title":"Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures","volume":"56","author":"Vegosen","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/imj.13061","article-title":"Seasonality of birth patterns in an Australian cohort of patients with biopsy-confirmed idiopathic inflammatory myopathy","volume":"46","author":"Woodman","year":"2016","journal-title":"Intern. Med. J."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib20","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/art.11090","article-title":"Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease","volume":"48","author":"Okada","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib22","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/art.37985","article-title":"Ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in Juvenile myositis","volume":"65","author":"Shah","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib23","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/rheumatology\/keq277","article-title":"Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"49","author":"Rider","year":"2010","journal-title":"Rheumatology"},{"issue":"50","key":"10.1016\/j.jaut.2023.103095_bib24","doi-asserted-by":"crossref","first-page":"34976","DOI":"10.1074\/jbc.M805383200","article-title":"UV radiation regulates Mi-2 through protein translation and stability","volume":"283","author":"Burd","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib25","first-page":"1342","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib26","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/acr.24059","article-title":"Association of ultraviolet radiation exposure with dermatomyositis in a national myositis patient registry","volume":"72","author":"Parks","year":"2020","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib27","doi-asserted-by":"crossref","DOI":"10.1186\/s12969-022-00684-9","article-title":"Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes","volume":"20","author":"Scalabrini","year":"2022","journal-title":"Pediatr. Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/annrheumdis-2012-201849","article-title":"Low serum levels of vitamin D in idiopathic inflammatory myopathies","volume":"72","author":"Azali","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.59.2.141","article-title":"The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient","volume":"59","author":"Hengstman","year":"2000","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1617-9","article-title":"Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-\u03b3 autoantibodies in adult patients with myositis","volume":"20","author":"Parkes","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib32","first-page":"802","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study","volume":"56","author":"Svensson","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.jaut.2023.103095_bib33","unstructured":"Ocused HLA Analysis in Idiopathic Inflammatory Myopathy Identifies Significant Associations of Classical HLA Alleles with Autoantibody and Clinical Subgroups."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1756-185X.2011.01669.x","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases","volume":"16","author":"Tan","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/ar3547","article-title":"Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan","volume":"13","author":"Muro","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib36","first-page":"221","article-title":"Silica-associated connective tissue disease: a study of 24 cases","volume":"74","author":"Koeger","year":"1995","journal-title":"M\u00e9d."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib37","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/art.39059","article-title":"Nested case-control study of selected systemic autoimmune diseases in world trade center rescue\/recovery workers","volume":"67","author":"Webber","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2023.103095_bib38","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/art.39260","article-title":"Antisynthetase antibodies in World Trade Center rescue and recovery workers with inflammatory myositis: comment on the article by Webber et al","volume":"67","author":"Selva-O\u2019Callaghan","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/acr2.11273","article-title":"Inorganic dust exposure during military service as a predictor of rheumatoid arthritis and other autoimmune conditions","volume":"3","author":"Ying","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10067-013-2467-0","article-title":"Occupational exposure in patients with the antisynthetase syndrome","volume":"33","author":"Labirua-Iturburu","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome \u2013 much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib42","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","volume":"48","author":"Schiffenbauer","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jaut.2023.103095_bib43","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/acr.22358","article-title":"Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy","volume":"66","author":"Orione","year":"2014","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12778","article-title":"Breastfeeding and autoimmunity: programing health from the beginning","volume":"79","author":"Vieira Borba","year":"2018","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/oxfordjournals.aje.a115348","article-title":"Connective tissue disease in Southeastern Georgia: a case-control study of etiologic factors","volume":"130","author":"Freni-titulaer","year":"1989","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib46","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/art.1780400822","article-title":"New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis","volume":"40","author":"Pachman","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2023.103095_bib47","first-page":"1","article-title":"Clinically amyopathic dermatomyositis caused by a tattoo","volume":"2018","author":"Han","year":"2018","journal-title":"Case Rep Rheumatol"},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.7326\/0003-4819-118-12-199306150-00002","article-title":"Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome","volume":"118","author":"Cukier","year":"1993","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib49","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0190-9622(96)90438-7","article-title":"Risk assessment of polymyositis\/dermatomyositis after treatment with injectable bovine collagen implants","volume":"34","author":"Hanke","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/art.1780370520","article-title":"Is there an association between injectable collagen and polymyositis\/dermatomyositis?","volume":"37","author":"Rosenberg","year":"1994","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib51","first-page":"950","article-title":"Environmental triggers of autoimmunity in anti-synthetase syndrome: the lungs under the spot light","volume":"31","author":"Kawano-Dourado","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib52","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s10067-014-2567-5","article-title":"Environmental exposure in inflammatory myositis","volume":"33","author":"Costa","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib53","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/annrheumdis-2017-211174","article-title":"Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study","volume":"76","author":"Svensson","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s004030050296","article-title":"Association between elevated serum antibody levels to streptococcal M12 protein and susceptibility to dermatomyositis","volume":"290","author":"Ichimiya","year":"1998","journal-title":"Arch. Dermatol. Res."},{"issue":"5 PART 1","key":"10.1016\/j.jaut.2023.103095_bib55","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3476(05)81905-5","article-title":"Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin","volume":"121","author":"Martini","year":"1992","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin diseases research registry","volume":"53","author":"Packman","year":"2005","journal-title":"Arthritis Care Res."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manlhiot","year":"2008","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ajh.10207","article-title":"CD4-CD8- T-cell polymyositis in a patient with chronic active Epstein-Barr virus infection","volume":"71","author":"Tsutsumi","year":"2002","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF01641089","article-title":"Polymyositis accompanying Coxsackie virus B2 infection","volume":"6","author":"Schiraldi","year":"1978","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib60","first-page":"86","article-title":"A case of polymyositis associated with hepatitis B infection","volume":"18","author":"Nojima","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib61","first-page":"370","article-title":"Inclusion body myositis associated with hepatitis C virus infection","volume":"92","author":"Tsuruta","year":"2001","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/clinids\/21.2.430","article-title":"Juvenile dermatomyositis in a child infected with human parvovirus B19","volume":"21","author":"Lewkonia","year":"1995","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00296-008-0702-9","article-title":"Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis","volume":"29","author":"Chandrakasan","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/art.11002","article-title":"Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome","volume":"49","author":"Johnson","year":"2003","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/nen.0b013e31815f38b7","article-title":"Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan","volume":"67","author":"Matsuura","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/art.1780380518","article-title":"Identification of human t cell leukemia\/lymphoma virus type i antibodies, dna, and protein in patients with polymyositis","volume":"38","author":"Sherman","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5877","article-title":"Antisynthetase Syndrome after chikungunya infection: a case report","volume":"10","author":"Tu\u00e3o","year":"2022","journal-title":"Clin Case Reports"},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib68","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0022-510X(73)90033-6","article-title":"Association of myasthenia gravis with pemphigus vulgaris, Candida albicans infection, polymyositis and myocarditis","volume":"20","author":"Namba","year":"1973","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib69","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/oxfordjournals.aje.a112341","article-title":"Childhood polymyositis: a case-control study","volume":"104","author":"Koch","year":"1976","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-021-01023-9","article-title":"COVID-19 and myositis: what we know so far","volume":"23","author":"Saud","year":"2021","journal-title":"Curr. Rheumatol. Rep."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib71","first-page":"E90","article-title":"Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy","volume":"61","author":"Okada","year":"2022","journal-title":"Rheumatol (United Kingdom)"},{"issue":"SI","key":"10.1016\/j.jaut.2023.103095_bib72","doi-asserted-by":"crossref","first-page":"SI96","DOI":"10.1093\/rheumatology\/keab290","article-title":"Onset of dermatomyositis in close association with COVID-19 - a first case reported","volume":"60","author":"Borges","year":"2021","journal-title":"Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-022-00271-1","article-title":"COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report","volume":"6","author":"Anderle","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-021-00225-z","article-title":"Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection","volume":"5","author":"Keshtkarjahromi","year":"2021","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.jaut.2023.103095_bib75","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jdcr.2021.04.036","article-title":"Dermatomyositis in a COVID-19 positive patient","volume":"13","author":"Ho","year":"2021","journal-title":"JAAD Case Reports"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10875-021-01119-y","article-title":"Onset and relapse of juvenile dermatomyositis following asymptomatic SARS-CoV-2 infection","volume":"42","author":"Rodero","year":"2022","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2023.103095_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1002329","article-title":"New-onset dermatomyositis following COVID-19: a case report","volume":"13","author":"Shimizu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103095_bib78","series-title":"COVID-19-Induced Sporadic Inclusion Body Myositis","author":"Dalal","year":"2022"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib79","doi-asserted-by":"crossref","DOI":"10.1259\/bjrcr.20200120","article-title":"COVID-19 related calcific myositis cases","volume":"7","author":"Tawfeeq","year":"2021","journal-title":"BJR|case reports"},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib80","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102666","article-title":"What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?","volume":"19","author":"De Lorenzis","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2023.103095_bib82","first-page":"12","article-title":"Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103095_bib83","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.29752","article-title":"Prevalence of myositis-specific autoantibodies and myositis-associated autoantibodies in COVID-19 patients: a pilot study and literature review","author":"Swartzman","year":"2022","journal-title":"Cureus. Published online"},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib84","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10067-022-06216-w","article-title":"Clinical evolution of antisynthetase syndrome after SARS-CoV2 infection: a 6-month follow-up analysis","volume":"41","author":"Vertui","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103095_bib85","first-page":"1","article-title":"Complete recovery from COVID-19 bilateral pneumonia in an immunosuppressed man with immune-mediated necrotizing myopathy","volume":"2020","author":"Bolig","year":"2020","journal-title":"Case Rep Rheumatol"},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib86","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2008.05.034","article-title":"Dermatomyositis induced by drug therapy: a review of case reports","volume":"59","author":"Seidler","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib87","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.7.4.421","article-title":"Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations","volume":"7","author":"Dourmishev","year":"2008","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib88","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies","volume":"48","author":"Mohassel","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib89","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/JND-170282","article-title":"Anti-HMGCR myopathy","volume":"5","author":"Mohassel","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.jaut.2023.103095_bib90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2020.11.015","article-title":"Natural compounds as anti-atherogenic agents: clinical evidence for improved cardiovascular outcomes","volume":"316","author":"Penson","year":"2021","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib91","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/L17-0620","article-title":"Immune-mediated necrotizing myopathy and dietary sources of statins","volume":"168","author":"Barbacki","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103095_bib92","series-title":"American College of Rheumatology Annual Meeting","article-title":"Did shiitake mushrooms induce immune-mediated necrotizing myopathy?","author":"Yoshida","year":"2019"},{"issue":"5","key":"10.1016\/j.jaut.2023.103095_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-248880","article-title":"Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy","volume":"15","author":"Adler","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/33.2.199","article-title":"Simvastatin-associated dermatomyositis","volume":"33","author":"Khattak","year":"1994","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib95","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0151-9638(05)79565-X","article-title":"Dermatomyosite induite par la fluvastatine","volume":"132","author":"Thual","year":"2005","journal-title":"Ann. Dermatol. Venereol."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib96","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.revmed.2005.07.005","article-title":"Dermatomyosite induite par la pravastatine","volume":"26","author":"Zuech","year":"2005","journal-title":"Rev. Med. Interne"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib97","first-page":"25","article-title":"Pravastatin-associated polymyositis, a case report","volume":"44","author":"Takagi","year":"2004","journal-title":"Clin. Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib98","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00296-017-3821-3","article-title":"Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review","volume":"38","author":"Borges","year":"2018","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib99","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/clc.23375","article-title":"Statin use in patients with non-HMGCR idiopathic inflammatory myopathies: a retrospective study","volume":"43","author":"Bae","year":"2020","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CRD.0b013e31816b43d3","article-title":"Fibrate therapy: an update","volume":"16","author":"Remick","year":"2008","journal-title":"Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1345\/aph.1M411","article-title":"Gemfibrozil-induced myositis in a patient with normal renal function","volume":"44","author":"Hahn","year":"2010","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib102","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0950-3579(05)80294-8","article-title":"Drug-induced myopathies","volume":"5","author":"Le Quintrec","year":"1991","journal-title":"Bailliere\u2019s Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib103","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/S0004-282X1992000100022","article-title":"Iatrogeny: the importance of clinical diagnosis. Clofibrate induced myopathy","volume":"50","author":"Godoy","year":"1992","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib104","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0248-8663(05)81354-2","article-title":"Polymyosite induite par le f\u00e9nofibrate","volume":"12","author":"Sauvaget","year":"1991","journal-title":"Rev. Med. Interne"},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.revmed.2003.10.013","article-title":"Polymyositis induced or associated with lipid-lowering drugs: five cases","volume":"25","author":"Fauchais","year":"2004","journal-title":"Rev. Med. Interne"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib106","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00124743-200202000-00011","article-title":"Drug-induced amyopathic dermatomyositis","volume":"8","author":"Flores-Su\u00e1rez","year":"2002","journal-title":"J. Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib107","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/ijms21093054","article-title":"Immune checkpoint inhibitor-related myositis: from biology to bedside","volume":"21","author":"Solimando","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2023.103095_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803410","article-title":"Incidence and distinct features of immune checkpoint inhibitor-related myositis from idiopathic inflammatory myositis: a single-center experience with systematic literature review and meta-analysis","volume":"12","author":"Hamada","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib109","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/RHU.0000000000001874","article-title":"Immune checkpoint inhibitor\u2013associated myositis: a distinct form of inflammatory myopathy","volume":"28","author":"Saygin","year":"2022","journal-title":"J. Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00296-014-2984-4","article-title":"Dermatomyositis as a complication of interferon-\u03b1 therapy: a case report and review of the literature","volume":"34","author":"Shiba","year":"2014","journal-title":"Rheumatol. Int."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib111","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2005.06.010","article-title":"Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b","volume":"37","author":"Venezia","year":"2005","journal-title":"Dig. Liver Dis."},{"issue":"8","key":"10.1016\/j.jaut.2023.103095_bib112","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.leu.2401104","article-title":"Symptomatic myopathy during interferon alfa therapy for chronic myelogenous leukemia [4]","volume":"12","author":"Falcone","year":"1998","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib113","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/qjmed\/91.6.393","article-title":"Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon","volume":"91","author":"K\u00e4lkner","year":"1998","journal-title":"QJM - Mon J Assoc Physicians"},{"issue":"12","key":"10.1016\/j.jaut.2023.103095_bib114","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2169\/internalmedicine.33.806","article-title":"The first case of polymyositis associated with interferon therapy","volume":"33","author":"Matsumoto","year":"1994","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jbspin.2010.07.012","article-title":"Anti-PL7 antisynthetase syndrome under interferon therapy","volume":"78","author":"Aouba","year":"2011","journal-title":"Jt Bone Spine"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib116","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","article-title":"Dermatomyositis after interferon alpha treatment","volume":"17","author":"Dietrich","year":"2000","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib117","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","article-title":"Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection","volume":"39","author":"Ferri","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib118","first-page":"147","article-title":"Polymyositis during pegylated \u03b1 - interferon ribavirin therapy for chronic hepatitis [7]","volume":"26","author":"John","year":"2007","journal-title":"Indian J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib119","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3346\/jkms.2002.17.1.141","article-title":"A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B","volume":"17","author":"Lee","year":"2002","journal-title":"J. Kor. Med. Sci."},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1212\/WNL.54.11.2186","article-title":"Myositis during long-term interferon-\u03b1 treatment","volume":"54","author":"Hengstman","year":"2000","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jaut.2023.103095_bib121","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002960050103","article-title":"Polymyositis occurring during \u03b1-interferon treatment for malignant melanoma: a case report and review of the literature","volume":"19","author":"Cirigliano","year":"1999","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib122","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1212\/01.WNL.0000133411.10574.BA","article-title":"Interferon \u03b2-responsive inclusion body myositis in a hepatitis C virus carrier","volume":"63","author":"Yakushiji","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/s10165-006-0523-1","article-title":"Polymyositis associated with infliximab treatment for rheumatoid arthritis","volume":"16","author":"Urata","year":"2006","journal-title":"Mod. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib124","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.22358","article-title":"Evolution of dermatomyositis during therapy with a tumor necrosis factor alpha inhibitor","volume":"55","author":"Hall","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03009740701281293","article-title":"Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma [4]","volume":"36","author":"Liozon","year":"2007","journal-title":"Scand. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib126","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3899\/jrheum.091413","article-title":"Dermatomyositis during adalimumab therapy for rheumatoid arthritis","volume":"37","author":"Brunasso","year":"2010","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib127","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archdermatol.2010.142","article-title":"Tumor necrosis factor inhibitor-associated dermatomyositis","volume":"146","author":"Klein","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10067-010-1666-1","article-title":"A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept","volume":"30","author":"Ishikawa","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib129","first-page":"192","article-title":"Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis","volume":"39","author":"Riolo","year":"2012","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.rbr.2015.12.005","article-title":"Three cases of anti-TNF induced myositis and literature review","volume":"57","author":"Zengin","year":"2017","journal-title":"Rev Bras Reumatol (English Ed."},{"issue":"2","key":"10.1016\/j.jaut.2023.103095_bib131","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.alit.2017.09.001","article-title":"A case of clinically amyopathic dermatomyositis that developed during anti-TNF-\u03b1 therapy for rheumatoid arthritis","volume":"67","author":"Takata","year":"2018","journal-title":"Allergol. Int."},{"issue":"10","key":"10.1016\/j.jaut.2023.103095_bib132","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamadermatol.2013.5220","article-title":"Dermatomyositis induced by anti-tumor necrosis factor in a patient with juvenile idiopathic arthritis","volume":"149","author":"Liu","year":"2013","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.jaut.2023.103095_bib133","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-\u03b1 therapies: a systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"Sci. World J."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib134","first-page":"13","article-title":"Rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome","volume":"95","author":"Ram\u00edrez-Rivera","year":"2003","journal-title":"Bol. Asoc. Med. P. R."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00296-007-0485-4","article-title":"HBV vaccine and dermatomyositis: is there an association?","volume":"28","author":"Altman","year":"2008","journal-title":"Rheumatol. Int."},{"issue":"17","key":"10.1016\/j.jaut.2023.103095_bib136","first-page":"675","article-title":"[Juvenile dermatomyositis concomitant with hepatitis B vaccination]","volume":"111","author":"Fernandez-Funez","year":"1998","journal-title":"Med. Clin."},{"issue":"8067","key":"10.1016\/j.jaut.2023.103095_bib137","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(78)90885-1","article-title":"Dermatomyositis after B.C.G. Vaccination","volume":"311","author":"K\u00e5ss","year":"1978","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.jaut.2023.103095_bib138","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/0264-410X(94)90166-X","article-title":"Influenza vaccine and dermatomyositis","volume":"12","author":"Jani","year":"1994","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib139","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archinte.1983.00350070177026","article-title":"Calcifying dermatomyositis following antitetanus vaccination","volume":"143","author":"Albert","year":"1983","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jaut.2023.103095_bib140","article-title":"Association of anti-SARS-COV-2 vaccine with increased incidence of myositis-related anti-RNA-synthetases auto-antibodies","volume":"5","author":"Garc\u00eda-Bravo","year":"2022","journal-title":"J Transl Autoimmun"},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib141","doi-asserted-by":"crossref","first-page":"A680","DOI":"10.1016\/j.chest.2021.07.646","article-title":"A rapidly progressive and rare illness: autoantibodies against melanoma differentiation-associated protein 5 (Anti-Mda5): amyopathic dermatomyositis with progressive interstitial lung disease that developed after covid-19 vaccine","volume":"160","author":"Carrasco","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib142","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00296-022-05149-6","article-title":"Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review","volume":"42","author":"Gonzalez","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib143","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-022-00250-6","article-title":"Dermatomyositis post vaccine against SARS-COV2","volume":"6","author":"Camargo Coronel","year":"2022","journal-title":"BMC Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2023.103095_bib144","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-022-03266-1","article-title":"Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports","volume":"16","author":"Vutipongsatorn","year":"2022","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jaut.2023.103095_bib145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2022.02.023","article-title":"COVID-19 vaccine-associated dermatomyositis","volume":"23","author":"Wu","year":"2022","journal-title":"JAAD Case Reports"},{"issue":"11","key":"10.1016\/j.jaut.2023.103095_bib146","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/ijd.16358","article-title":"Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine","volume":"61","author":"Ooi","year":"2022","journal-title":"Int. J. Dermatol."},{"issue":"10","key":"10.1016\/j.jaut.2023.103095_bib147","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15749","article-title":"Vaccine-induced dermatomyositis following COVID-19 vaccination","volume":"35","author":"Chaima","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib148","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15479","article-title":"Dermatomyositis following COVID-19 vaccination","volume":"35","author":"Venkateswaran","year":"2022","journal-title":"Dermatol. Ther."},{"issue":"10","key":"10.1016\/j.jaut.2023.103095_bib149","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/imj.15882","article-title":"Polymyositis and raised troponin after mRNA COVID-19 vaccination","volume":"52","author":"Ciofani","year":"2022","journal-title":"Intern. Med. J."},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.5114\/reum.2021.111836","article-title":"COVID-19 vaccination-associated anti-Jo-1 syndrome","volume":"59","author":"Gupta","year":"2021","journal-title":"Reumatologia"},{"issue":"6","key":"10.1016\/j.jaut.2023.103095_bib151","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1002\/mus.27531","article-title":"A temporal association between COVID-19 vaccination and immune-mediated necrotizing myopathy","volume":"65","author":"Tan","year":"2022","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.jaut.2023.103095_bib152","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1111\/jdv.18211","article-title":"Onset of amyopathic dermatomyositis following mRNA-based SARS-CoV-2 vaccination","volume":"36","author":"Kreuter","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"7","key":"10.1016\/j.jaut.2023.103095_bib153","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11739-022-03028-3","article-title":"Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study","volume":"17","author":"Conticini","year":"2022","journal-title":"Intern Emerg Med"},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib154","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mus.27681","article-title":"COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies","volume":"66","author":"Gil-Vila","year":"2022","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jaut.2023.103095_bib155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10067-004-0890-y","article-title":"A case of anti-Jo1 myositis with pleural effusions and pericardial tamponade developing after exposure to a fermented Kombucha beverage","volume":"23","author":"Derk","year":"2004","journal-title":"Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2023.103095_bib156","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2018.08.019","article-title":"Acute onset\/flares of dermatomyositis following ingestion of IsaLean herbal supplement: clinical and immunostimulatory findings","volume":"80","author":"Zeidi","year":"2019","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112300104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112300104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:33:24Z","timestamp":1760258004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112300104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":156,"alternative-id":["S089684112300104X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103095","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental exposures as risk factors for idiopathic inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103095"}}